Qingsong Consortium Launches 'Huddle for Warmth to Navigate the Winter' Initiative, Partnering with Investors, Big Pharma, and MNCs to Support Biotech Financing and BD Collaborations

Over the past four months, impacted by the pandemic and a sharp correction in the capital markets, the biopharmaceutical industry has faced challenges such as slowed financing and decelerated partnerships.

In response, Qingsong will integrate resources from its ecosystem partners,JointEli Lilly Asia Venture Fund, Qiming Venture Partners, Sequoia Capital, Danlu Capital, Guoke Jiahe, Johnson & Johnson, Pfizer, Abbott, Hengrui Medicine, Sino Biopharmaceutical, CSPC Pharmaceutical GroupMainstream biomedical capital and large pharmaceutical companies,Specially Curated Launch from May to July“Navigating the Capital and Pandemic Winter: Survival First” Series。

In this series of events, we have arranged[Online Roadshow] [Live VC Interviews] [Qingsong Bio Member Offline Meeting Day] Three Major Themed Events, by facilitating connections to capital and industrial resources, amplifying visibility within the venture capital community, and fostering in-depth offline exchanges, we empower Qingsong Bio Trailblazer members and partners to enhance their fundraising capabilities and business collaboration skills, thereby advancing the execution of financing and business development (BD) partnerships during the economic downturn.

Qingsong Financing + BD Collaboration Online Roadshow

Amid a sluggish market environment, only 20–30% of primary-market investment firms have maintained basically normal operations, 50–60% have significantly slowed their pace, and the remaining 10–20% have become completely inactive. Compounded by the impact of the pandemic,Biotechnology companies are encountering significant obstacles in securing financing.

On the other hand, both established pharmaceutical companies and biotechnology firms have recognized the wisdom of “uniting to weather the winter,” focusing more intently on their R&D pipelines,We are also beginning to focus more on licensing and business development (BD) collaboration opportunities.

Survival in Adversity: May–July【Qingsong Financing + BD Collaboration Series Online Roadshow】 will help Qingsong Bio Leaders members and partners secure more opportunities to present themselves to investment institutions and collaborators., and more actively promote financing and collaboration.The first roadshow will take place on May 19 (next Thursday).

Qingsong Venture Capital Interview Livestream

Qingsong Venture Capital Interview Livestream is positioned as a platform for sharing practical experience in entrepreneurship and investment, featuring 1–3 guests per episode.

We focus on interviewees’ shared experiences of success in technological innovation, financing, and collaboration; we also pay close attention to how they navigate adversity, overcome challenges, and break through impasses.

The first live broadcast is scheduled for May 28, specially invitedAssistant to the President of Fosun Pharma’s Global R&D Center, Wu Wei; Head of Johnson & Johnson Innovation Investment, Zhu Fangfang, Founder of Xueji Biotech, to jointly explore“Amid the ‘Winter Chill’: Crises and Opportunities for Biotechnology Companies”。

(Scan the QR code to schedule and watch the live stream)

Qingsong Bio In-Person Meeting Day

This spring, the pandemic briefly prevented us from meeting in person.

Following the lifting of pandemic restrictions, members of the Qingsong Bio Leaders program and their partners will reunite in person once again. Let us share our thoughts, address each other’s questions, discuss recent experiences and reflections, and explore future plans and collaborations.

Qingsong Meeting Day: Past Events

There may be many foreseeable and unforeseen challenges in the present and future, but here we stand together for warmth and support, walking hand in hand.

May Qingsong help you sail with full sails, navigating through the pandemic and the capital winter, and firmly moving towards tomorrow...